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A reverse genetics cell-based evaluation of genes linked
to healthy human tissue age
Hannah Crossland,* Philip J. Atherton,† Anna Stro¨mberg,‡ Thomas Gustafsson,‡ and James A. Timmons*,1
*Division of Genetics and Molecular Medicine, King’s College London, Guy’s Hospital, London, United Kingdom; †School of Medicine,
University of Nottingham, Royal Derby Hospital, Derby, United Kingdom; and ‡Department of Laboratory Medicine, Clinical Physiology,
Karolinska University Hospital, Stockholm, Sweden
ABSTRACT: We recently developed a binary (i.e., young vs. old) classifier using human muscle RNA profiles that
accuratelydistinguished the age ofmultiple tissue types. Pathway analysis didnot reveal regulators of these 150 genes,
so we used reverse genetics and pharmacologic methods to explore regulation of gene expression. Using small in-
terfering RNA, well-studied age-related factors (i.e., rapamycin, resveratrol, TNF-a, and staurosporine), quantitative
real-timePCRandclusteringanalysis,westudiedgene–gene interactions inhumanskeletalmuscleandrenalepithelial
cells. Individual knockdown of 10 different age genes yielded a consistent pattern of gene expression in muscle and
renal cells, similar to in vivo. Potential epigenetic interactions included HIST1H3E knockdown, leading to decreased
PHF19 and PCDH9, and increased ICAM5 in muscle and renal cells, while ICAM5 knockdown reduced HIST1H3E
expression. Resveratrol, staurosporine, and TNF-a significantly regulated the in vivo aging genes, while only rapa-
mycinperturbed thehealthy-agegeneexpression signature inamanner consistentwith invivo. Invitro coordinationof
geneexpressionfor this invivo tissueagesignature indicatesadegreeofdirect coordination, and theobserved linkwith
mTORactivity suggests a direct linkbetweena robust biomarker of healthyneuromuscular age andamajor axis of life
span inmodel systems.—Crossland,H.,Atherton,P. J., Stro¨mberg,A.,Gustafsson,T.,Timmons, J.A.Areversegenetics
cell-based evaluation of genes linked to healthy human tissue age. FASEB J. 31, 000–000 (2017). www.fasebj.org
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Chronological age is a major correlate for many diseases,
including Alzheimer disease, cancer, and cardiovascular
diseases. It has been hypothesized that differences in the
rate of biologic aging represent an important reason why,
along with key environmental factors, each human can
develop age-correlated disease at different chronological
ages (1). For this reason, it is important that robust bio-
markers of biologic age are developed to facilitate a more
personalized approach to health care. For example, such a
biomarker couldbe applied tomiddle-aged subjects for the
purposeofofferingdiseasepreventionadvice.Theanalysis
of gene expression changes with aging using microarray
technology represents one important technology to realize
this aim. Indeed, several meta-analyses studying different
tissues and organisms have been used in an attempt
identify common signatures of aging (2–6).
The majority of studies have used linear regression to
build models that span ,20 to .100 yr (6–8). However,
when studying humans, this type of molecular profiling
incorporates not only markers of age but also clinical dis-
ease and complex interactions with drug treatment that
are currently impossible to deconvolute. Further, as a re-
sult of population stratification and changes in the genetic
contribution to survival beyond 80 yr (9), these types of
linear correlative approaches areproblematic.We recently
took a different approach: we used machine learning to
distinguish muscle tissue obtained from healthy older
subjects with functional capacity matched to younger
subjects (i.e., a binary classifier and not a linear correlative
model). Using thousands of samples, we validated a 150-
gene RNA tissue diagnostic able to accurately (.90%
performance in independent samples) classify young from
older human muscle, brain, and skin tissue (5). Gene ex-
pression changes with age were hypothesized to be
adaptive, and hence regulation of the gene expression
pattern is potentially beneficial to health. Notably, given
that the signature was discovered in human muscle, ex-
ercise training does not regulate the healthy aging profile.
Indeed, when comparing chronological age–matched
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cases andcontrols, this reproducible signatureof tissueage
was diagnostic for cognitive status in 2 independent co-
horts aswell as being related to renal function over a 12-yr
follow-up period in older men belonging to a birth cohort
and hence the same chronological age (10). In each study,
the more the gene expression pattern matched the pattern
observed in healthy older muscle tissue (5), the better the
health status the older person had compared to someone
with a similar chronological age but lower gene score.
Surprisingly, pathway and gene ontology analysis
failed to identify any dominant pathway in the 150 genes
(5). Individually, some of the 150 genes did show links to
published age-related phenotypes, such as LMNA, a gene
encoding a nuclear lamina protein that is linked to
Hutchinson-Gilford progeria syndrome (11). However,
for the majority of the genes, little was known about their
biologic function, particularly in relation to aging. Never-
theless, our analysis in multiple human cohorts suggests
that regulation of these genes may contribute to healthy
aging, and investigation of how these genes are regulated
or interact is therefore required to provide greater un-
derstanding into mechanisms of human aging.
The main aim of the present study was to determine
whether interactions existed between individualmembers
of the gene set, and in particular if we could replicate the
pattern of regulation in vivo. To achieve this aim, we used
small interfering RNA (siRNA)-mediated gene knock-
down and putative pro- (staurosporine and TNF-a) or
anti- (resveratrol and rapamycin) age-related molecules.
We found that the age classifier genes demonstrated co-
ordinated changes in vitro that paralleled the up-
regulation of gene changes with age in vivo. Further, we
found evidence that rapamycin induced expression
changes reflecting the same directional changes observed
in vivo in healthy human muscle with age.
MATERIALS AND METHODS
Cell culture, siRNA, and drug treatments
Human primary skeletal muscle cells were established from
muscle biopsy samples from healthy young adult men as pre-
viouslydescribed (12). Thisprocedurewasapprovedby the ethics
committee of the Karolinska Institutet (Stockholm, Sweden). Iso-
latedmyoblasts (passages 4 and 5)were cultured on uncoated 12-
well plates in DMEM/Nutrient Mixture F-12 (Thermo Fisher
Scientific,Waltham,MA,USA) containing 20% (v/v) fetal bovine
serum (Sigma-Aldrich, St. Louis, MO, USA), 4 mM L-glutamine,
and 1% (v/v) antibiotic–antimycotic solution (Thermo Fisher
Scientific). Cells were cultured at 37°C with 5% CO2. When cells
were approximately 90% confluent, differentiation was induced
by switching the medium to DMEM/F-12 containing 2% (v/v)
horse serum (Sigma-Aldrich), 4 mM L-glutamine, and 1% (v/v)
antibiotic–antimycotic solution (Thermo Fisher Scientific). Hu-
man primary renal epithelial cells were obtained from Promocell
(c-12665; Heidelberg, Germany) and were cultured in Promocell
growthmedium. siRNAexperimentswereperformedatpassages
5 and 6.When cellswere approximately 50% confluent, theywere
transfected (Lipofectamine RNAiMax) with 20 nM siRNA (same
siRNAs as for the muscle cell experiments). After 48 h, cells were
collected in Trizol (Thermo Fisher Scientific).
For each siRNA experiment, 2 separate siRNA sequences
were used [On-TargetPlus from Dharmacon (Lafayette, CO,
USA) or Silencer Select fromThermoFisher Scientific], and4-well
replicates were used for each treatment. Three to 4 independent
experiments were carried out for each siRNA treatment and cell
type. For siRNA transfection of primary muscle cells, when
myoblasts were approximately 100% confluent, they were
switched to differentiation medium and transfected 48 h there-
after. Cellswere transfectedwith 20 nMsiRNA targetingAIMP2,
NPEPL1, PHF19, ICAM5, SLC38A10, HIST1H3E, LMNA,
RUNX1, SHISA4, and CARM1 using Lipofectamine RNAiMAX
transfection reagent (Thermo Fisher Scientific). Sequences of
siRNA used were as follows (59 to 39): CAUAAUGCUGU-
CAACGCAA and CCAAUGCGCUGGACUUGAA for AIMP2,
GGACAUGUCUGCUUAUUGC and GAAGGAGAUUUGCA-
CAGGA for CARM1, GCGCAUCGCUGCAUUGUGA and
GCAAUGAGAUGAACACCGA for NPEPL1, UGUGGUAC-
CUGGACCGGAA and GGAGCUGAACUAGAACUAU for
SHISA4, CCGGAGAUGGAUGAAUCUA and GUGACCAU-
CUACAGCUUCC for ICAM5, GGCAGAAACUAGAU-
GAUCA and GCUGAGCUGAGAAAUA for RUNX1,
AGAAACAAGAGCCGGAGCA and AGCCGUCAGUGAAAA-
CCAU for SLC38A10, CCAAAAAGCGCAAACUGGA and
GAAGGAGGGUGACCUGAU for LMNA,GACUUGAUGUCC-
AAACUGA and GCCUCGUGACUUUCGAAGA for PHF19,
and CCAGAAGUCUACCGAGCUU and GCGUGAAUU-
GUUUUGAGUA for HIST1H3E. Controls were performed with
transfection reagent only, and each siRNAwas tested for efficacy in
initial experiments. Toxicity was checked in initial experiments to
assess viability of the cells (annexin V/propidium iodine staining).
Cells were collected in Trizol 48 h after transfection.
For drug treatment studies, experiments were performed
on human primary muscle cells 6 d after switching to differ-
entiation medium and 24 h after a medium change. Myotubes
were treated for 24 h with the following chemicals: 100 nM
rapamycin (Sigma-Aldrich), 50 mM resveratrol (Sigma-
Aldrich), 10 ng/ml TNF-a (Sigma-Aldrich), and 10 nM staur-
osporine (Sigma-Aldrich). Bovine serum albumin [BSA; final
concentration 0.0001% (w/v)] was used as a vehicle control
for TNF-a, and DMSO [final concentration 0.03% (v/v)] was
used as a vehicle control for rapamycin, resveratrol, and
staurosporine. Cells were collected in Trizol, and each ex-
periment was repeated over 3 passages (n = 4 well replicates
for each experiment).
Annexin V/propidium iodide staining of human
renal epithelial cells
Human renal epithelial cells were cultured in 6-well plates and
transfected with 20 nM siRNA at ;50% confluence. After 48 h,
the mediumwas removed, and cells were washed in warm PBS.
Cells were incubated in a solution containing annexin V–FITC
conjugate and propidium iodide using an annexin V–FITC ap-
optosis detection kit (Sigma-Aldrich). After 10 min incubation at
room temperature, cells were fixed using ice-cold methanol:
acetone, washed in PBS, mounted, and stainedwith DAPI using
Fluoroshield mounting mediumwith DAPI.
RNA extraction, cDNA synthesis, and real-time
quantitative PCR
RNAwas extracted using Trizol according to themanufacturer’s
protocol.RNAwas resuspended in20ml ofRNase-freewater and
quantified using a NanoDrop (Thermo Fisher Scientific). RNA
(500 ng) was reverse transcribed using the High Capacity cDNA
synthesis kit (Thermo Fisher Scientific). cDNA was diluted 1:5,
and real-timequantitativePCR (qPCR)wasperformedusing 1ml
cDNA in triplicate with 10 ml master mix containing the follow-
ing: SYBR Select Master Mix (Thermo Fisher Scientific) and
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primers designed to target the following genes:AIMP2,NPEPL1,
CALR, PHF19, ICAM5, SLC38A10, HIST1H3E, LMNA, RUNX1,
SHISA4, CARM1, SIRT5, MBNL1, SKAP2, CFLAR, ALDH6A1,
TGFBR3, CD36, RBMS3, and PCDH9.
The following primer sequences were used (59–39): AIMP2,
forward TGGGATTCACTTTAATTTGGAAG, reverse
GTTCCCTTCGCCTTCGAT; CARM1, forward AACCACACC-
GACTTCAAGGA, reverse AAAAACGACAGGATCCCAGA;
NPEPL1, forward GGGCAAAGGCATCGTCTA, reverse CCC-
GGCATGGTAGTCTTC; SHISA4, forward GGCCCCCAGTC-
TACAACC, reverse ATCTCCCAAGGTTGGCATC; ICAM5,
forward GAGTCCTGATGTCACCCTCG, reverse CCGGGAA-
GCTGTAGATGGTC; RUNX1, forward CTCCCTGAACCA-
CTCCACTG, reverse TGGGGATGGTTGGATCTG; SLC38A10,
forward CGTCAGTGAAAACCATGAGC, reverse AGCT-
GACGTAGCCGAAAAAC; LMNA, forward CTGGTCACC-
CGCTCCTAC, reverse TGGCAGGTCCCAGATTACAT; PHF19,
forward AAAGTTTTTGCTGGAAGATGCT, reverse TTGA-
ATTTCATCCAGCGTGA; HIST1H3E, forward CTCGTAAA-
TCCACAGGCGGT, reverse TAGCGATGGGGCTTCTTCAC;
CALR, forward CTATGATAACTTTGGCGTGCTG, reverse
ACTCCTCAGCGTATGCCTCA; SIRT5, forward GCTCGGC-
CAAGTTCAAGTATG, reverse CCTCTGAAGGTCGGAA-
CACC; MBNL1, forward CTGCCCAATACCAGGTCAAC,
reverse GGGGAAGTACAGCTTGAGGA; SKAP2, forward
TCCCTAACATGCCCAACC, reverse TTTTCTCCTTTCAG-
TATATCTGCTACA; CD36, forward CCTCCTTGGCCTGA-
TAGAAA, reverse GTTTGTGCTTGAGCCAGGTT; PCDH9,
forward GCCCCTTACACACCAGACAG, reverse TTCAT-
TCTCCTGAATGTGGAAA; ALDH6A1, forward CAGGTCT-
TGCTCCGCTATCAA, reverseGGCATGCTCAACCACCTGAAG;
RBMS3, forward AGTTCCCTGCCTCGGAGATA, reverse
CTGGTGCATAGGACTGCTTG; CFLAR, forward AAGTC-
CGCTTCCAGGCTTTC, reverse TCCAGTGGGGGAGTTCG-
TC; TGFBR3, forward CCAGCTACAGAGAGAGGTCAC,
reverse CCACAGAACCCTCAGACACC; ACTB, forward
GAGCACAGAGCCTCGCCTTT, reverse CATCATCCATGG-
TGAGCTGG.
Thermal cycling conditions were 2 min at 50°C, 10 min at
95°C, and 40 cycles of 15 s at 95°C and 1 min at 60°C. Samples
were run on a Viia 7 qPCR machine (Thermo Fisher Scientific).
For normalization, b-actin (ACTB) expression was measured
(none of the treatments affected b-actin expression; data not
shown). The DCt method (13) was used to calculate relative
changes in target mRNA abundance.
Statistical analyses
For siRNA experiments, 2-way ANOVA with Sidak’s multiple
comparison test was used to test for the main effects of each
siRNA treatment and the statistical significance of each gene
between control and siRNA-treated groups, correcting for mul-
tiple testing. For drug treatment experiments, 2-way ANOVA
was initially used to testwhether each compound had an overall
effect on mRNA expression. Our second aim with this analysis
was to determine whether the changes in gene expression with
each drug treatment reflected the directional patterns seen with
aging in vivo (i.e.,whether genes up-regulated in vivowith aging
were up-regulated by the drug treatment and vice versa). For
those genes affected by the drug treatment, genes were assigned
either 1 (if its direction of change matched the observed change
with age in vivo) or 0 (if its direction of changewas opposite to the
observed changewith age in vivo). Fisher’s exact test was used to
determine the significance of the observed changes vs. the
expected changes. Thus, a result of P , 0.05 indicated that the
gene expression changeswith eachdrug treatmentweredifferent
from the directional changes in vivowith aging. Overall, Fisher’s
exact test allowed us to assess consistency (i.e.,whether the drug
RNA response was similar or distinct from the in vivo pattern of
changes with muscle tissue aging).
Distance-based cluster analysis was used assess the relation-
ship between gene expression responses across all experiments.
The analysis was done in the R statistical environment (https://
cran.r-project.org) using the library package Library(gplots)
and Euclidean-based distance, with the setting Complete.
Gene expression was calculated as a percentage of control,
and row- and column-based clustering was implemented.
This approach represents a robust method for assessing how
groups of conditions may or may not relate to each other (in
this case using Euclidean distance) based on the accumulated
influence of each phenotype measured (in this case gene ex-
pression). Principal component analysis was carried out on
the published muscle gene expression data using the 150
probe sets. In R, the following command was implemented:
pcaData , -prcomp[t(data(,)], center = T, scale = T, and the
first 2 principal components were plotted and genes selected
that fulfilled 2 criteria: 1) demonstration of distinct and mea-
surable location in the principal component analysis plot and
2) detectable by real-time qPCR in the cell culture system.
RESULTS
Twenty genes were selected after root–mean–square
normalized principal component analysis of the original
biologic age model that distinguished young from old
healthy human skeletal muscle with ;93% success (5).
These 20 were chosen because they demonstrated a high
degree of variance and because they were robustly
expressed inboth cell typesused for the in vitro studies.We
plotted the expression of these 20 genes in skeletal muscle
profiles obtained from young (mean age 26 yr; n = 10),
middle-aged (mean age 49 yr; n = 19), and old (mean age
70 yr; n = 16) healthy subjects using our previously pub-
lishedmicroarray data (4) to examine the changes across 4
decades (Fig. 1). This analysis demonstrated that there
were several categories of patterns of gene expression
change. Nine demonstrated a potentially linear pattern of
change, while the remainder demonstrated a dramatic
step either atyoung tomiddle ageormiddleage tooldage.
[This pattern is expected, as the selection process for the
150 genes relied on a nonlinear selection process (5).] As
with the ontology/pathway analysis for the full 150 genes
(5), this subset of 20 genes did not fall into any specific
ontologic pathway. Furthermore, a manual search of the
GenAge database revealed that only one of the 20 genes
(LMNA) was found to be associated with aging in other
model organisms. However, using a simple literature
analysis, the known biologic functions attributed to the 20
geneswas evaluated,with some biochemical ormolecular
properties relating to proposed mechanisms for aging
(Table 1), including epigenetic regulation (CARM1,
HIST1H3E), lipid metabolism (CD36), and stem cell func-
tion (RUNX1).
siRNA-mediated knockdown of age classifier
genes in human skeletal muscle and
kidney cells
Tengenes,down-regulated invivowithmuscle age (Fig. 1),
were selected for individual siRNA-mediated knockdown
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(2 independent siRNAs and a total of 60 independent cell
cultures) to examine the interrelationship been each gene
and the remaining 19 from the age classifier (5). Because
the classifier was diagnostic for age across different tissue
types, we wished to establish if any individual gene
knockdown mediated responses that were consistent
across more than one human cell type. We chose to use
human primary skeletalmuscle cells because the age gene
classifier was built on skeletal muscle tissue and renal
epithelial cells, as the age genes were shown to be corre-
latedwith renal function over a 12-yr span (5).We verified
that the siRNAs did not cause any obvious adverse effects
related to cell health/viability using renal cells used for
immunofluorescence staining against annexin V and
propidium iodide to assess apoptosis status and evidence
for necrosis, respectively (Supplemental Fig. 1). Initial real-
time qPCR analysis revealed no effect of the transfection
reagent on any of the genes analyzed (data not shown) in
either cell type.
Individual knockdown of the 10 selected age classi-
fier genes induced multiple expression changes in the
remaining 19 genes. To determine the global relationship
across all siRNA experiments, we used distance-based
clustering (Euclidean) and grouped the entire data set
according to siRNA target (Fig. 2A) or according to gene
(Fig. 2B). We observed that 70% of siRNA targeted genes
produced a relatively consistent pattern of gene expres-
sion responses in muscle and renal cells (i.e., the nearest
neighbor of an siRNA in renal cellswas the same siRNA in
muscle cells) (Fig. 2A), while genes like ICAM5 appeared
to produce a more cell-type-specific response on the basis
of this cluster analysis. Overall, the consistent response in
both renal and muscle cells supports our original in vivo
analysis (5).
Clustering by gene expression rather than by siRNA
treatment revealed an intriguing result,wheremanyof the
genes (CD36,MBNL1, PCDH9, RBMS9, andTGFBR3) that
are up-regulated in vivo with age in healthy muscle were
up-regulated across all experiments (regardless of which
genewas being down-regulated). This indicates that these
genesmaybeup-regulated in vivoas a secondary response
to down-regulation of key members of the 150 genes. We
also noted, as expected, that genes down-regulated in vivo
clustered together (Fig. 2B), partly reflecting the fact that
we experimentally knocked down half of those genes
while the remaining genes that were down-regulated in
vivo nevertheless clustered with these down-regulated
genes and not with the distinct group of in vivo up-
regulated genes.
There were some cell-type-specific patterns; for ex-
ample, in human primary skeletal muscle cells, knock-
down of ICAM5, HIST1H3E, SHISA4, RUNX1 AIMP2,
LMNA, and SLC38A10 had a significant impact on the
other age genes overall (P , 0.05, P , 0.05, P , 0.05,
P , 0.01, P , 0.01, P , 0.001, P , 0.001 vs. control,
respectively; 2-way ANOVA main effect; Fig. 3A, C),
whereas siRNA-mediated knockdown of NPEPL1,
CARM1, and PHF19 mRNA had minimal impact on
expression of the other age genes in these cells (Fig. 4).
In human primary renal epithelial cells, ICAM5,
HIST1H3E, and AIMP2 had an overall effect on classi-
fier gene expression (P , 0.001, P , 0.05, P , 0.001 vs.
control, respectively; 2-way ANOVA main effect; Fig.
3B, D), whereas the remaining genes had little impact
(Fig. 5).
In muscle cells, knockdown of ICAM5 caused a sig-
nificant change in expression of 4 of the other age genes
(HIST1H3E was decreased and RUNX1, CARM1, and
SIRT5 were increased (Fig. 3A). ICAM5 knockdown in
kidney cells also down-regulated HIST1H3E (along with
PHF19), while SHISA4, TGFBR3, CD36, and PCDH9
were up-regulated (Fig. 3B). HIST1H3E knockdown also
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Figure 1. Expression intensity values for 20 age classiﬁer genes (5) using previously published microarray data from human
skeletal muscle across different age groups (4). Bars represent means 6 SEM, and data are normalized to average of young group.
Red/blue bars represent down-/up-regulated genes with aging in vivo.
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affected several age genes with a relatively consistent
effect across muscle and renal cells (Fig. 3C, D). Thus,
the response of HIST1H3E appeared consistent across
cell types, and HIST1H3E was the most regulated gene
in vivo. Knockdown of the remaining 8 genes had
varying effects on expression of the other age classifier
genes (Figs. 4 and 5). Overall, the degree of statistical
significance for individual genes will be reflective of
sample size, and in general, the more powerful
methodology—cluster analysis—revealed coordinated
gene expression changes.
Effects of selected age-associated chemical
mediators on expression of age
classifier genes
Another key facet warranting exploration is the impact of
putative positive/negative regulators of tissue aging on
healthy tissue age genes. Thus, skeletal muscle cells were
treated with selected age-related factors in an effort to as-
sess if each tissue age gene might be regulated by these
aging-related chemicals. For each individual treatment,
control genes known tobe associatedwith that compound
were measured as confirmation of activity in our cells
(Supplemental Fig. 2). Initial experiments alsoverified that
the vehicle controls DMSO and BSA had no effect on ex-
pression of the 20 age genes (Supplemental Fig. 3).
Resveratrol is a naturally occurring polyphenolic com-
pound with antioxidant activity that activates SIRT1,
an NAD+-dependent histone deacetylase, and possibly
AMPK (14, 15). Resveratrol has reported antiaging effects
in yeast (14), flies (16), and, in some studies, mice (17, 18).
Treatment of differentiated skeletal muscle cells with
resveratrol had an overall effect on expression of the age
classifier genes as assessed byANOVA (P, 0.05; Fig. 6A),
but these changes were significantly different from the
TABLE 1. Selected age classiﬁer genes and their known biologic functions
No.
Gene
symbol Gene name
Direction
with age Biology
1 RUNX1 Runt-related transcription factor 1 Down Transcription factor; differentiation of hemopoietic
stem cells
2 PHF19 PHD ﬁnger protein 19 Down Binds methylated histone H3 and recruits polycomb
repressive complex 2
3 ICAM5 Intercellular adhesion molecule 5,
telencephalon
Down Transmembrane glycoprotein involved in adhesion
4 SLC38A10 Solute carrier family 38, member 10 Down Putative neutral amino acid transporter
5 SIRT5 Sirtuin 5 Down NAD-dependent protein deacetylase; mitochondrial
6 HIST1H3E Histone cluster 1, H3e Down Replication-dependent histone; core component of
nucleosome
7 CALR Calreticulin Down Calcium binding protein in endoplasmic reticulum;
protein folding; possible nuclear receptor
modulation
8 NPEPL1 Aminopeptidase-like 1 Down May catalyze removal of unsubstituted N-terminal AA
from various peptides
9 CARM1 Coactivator-associated arginine
methyltransferase 1
Down Methylates histones and chromatin-associated
proteins
10 LMNA Lamin A/C Down Mutation linked to Hutchinson-Gilford progeria
syndrome; nuclear membrane structural
component; DNA replication; chromatin
organization
11 SHISA4 Shisa homolog 4 (Xenopus laevis) Down Transmembrane protein; may inhibit Wnt and FGF
signaling
12 AIMP2 Aminoacyl tRNA synthetase complex-
interacting multifunctional protein 2
Down Required for aminoacyl-tRNA synthase complex
assembly; proapoptotic
13 TGFBR3 TGF, b receptor III (b-glycan, 300 kDa) Up Membrane proteoglycan that acts as coreceptor with
other TGF-b receptor superfamily members
14 CD36 CD36 molecule (thrombospondin
receptor)
Up Receptor for oxidized lipids
15 MBNL1 Muscle blind-like 1 Up RNA binding; regulates splicing
16 SKAP2 Src kinase–associated phosphoprotein 2 Up Adapter protein; actin assembly/stress ﬁber
formation;
17 CFLAR CASP8- and FADD-like apoptosis
regulator
Up Apoptosis regulator; lacks caspase activity;
overexpression impacts on muscle satellite cell
proliferation
18 PCDH9 Protocadherin 9 Up Ca2+-dependent transmembrane protein important
in cell adhesion in neural tissues
19 RBMS3 RNA binding motif, single-stranded
interacting protein 3
Up RNA binding protein
20 ALDH6A1 Aldehyde dehydrogenase 6 family,
member A1
Up Mitochondrial; valine and pyrimidine catabolic
pathways
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pattern of in vivo changes seen between old and young
tissue (P = 0.0033 with Fisher’s exact test). Induction of
SIRT1 and AMPK gene expression by resveratrol con-
firmed expected features of resveratrol treatment (Sup-
plemental Fig. 2).
Rapamycin is an antibiotic that binds to and inhibits
mTOR, a nutrient-responsive kinase that influences
metabolism and cellular growth via the PI3K/AKT
pathway (19). Genetic or pharmacologic inhibition of
mTOR extends the life span ofCaenorhabditis elegans (20),
Saccharomyces cerevisiae (21), and mice (18, 22). Rapa-
mycin treatment reduced EIF4E and S6K, as expected
(Supplemental Fig. 2). Rapamycin also had an effect on
expression of the age classifier genes (P, 0.05 by 2-way
ANOVA) andmoreover induced apattern of change that
was not different from the pattern of changes noted in
vivowith tissue age (Fig. 6B;P=0.2273withFisher’s exact
test). Thus, rapamycin treatment altered gene expression
in our cell studies in a manner similar to that observed
with tissue age in healthy old muscle.
There are also compounds that actively regulate
detrimental age-related phenotypes. It has been pro-
posed that reduced autophagic capacity with aging
may be responsible for increased expression of proin-
flammatory mediators that result from mitochondrial
dysfunction and increased reactive oxygen species
(ROS) production (23). TNF-a was also chosen as a
proaging factor because aging in older humanshas been
correlated with a proinflammatory phenotype (24).
Staurosporine is a potent inducer of oxidative stress,
and excessive ROS can impair oxidative phosphoryla-
tion and promote accumulation of mitochondrial DNA
mutations, leading to widespread cellular damage and
numerous features of aging (25, 26). Muscle cells were
treated for 24 h with TNF-a and staurosporine, and
changes in expression of positive control (Supplemental
C
D
36
M
B
N
L1
P
C
D
H
9
R
B
M
S
9
TG
FB
R
3
IC
A
M
5
R
U
N
X
1
A
IM
P
2
S
H
IS
A
4
S
IR
T5
H
IS
T1
H
3E
P
H
F1
9
C
A
R
M
1
S
LC
38
A
10
LM
N
A
C
A
LR
S
K
A
P
2
N
P
E
P
L1
C
FL
A
R
A
LD
6H
A
1
Age gene
Clustering by Age-gene response
m
R
U
N
X
1
kA
IM
P
2
m
A
IM
P
2
m
S
LC
38A
10
m
LM
N
A
kS
H
IS
A
4
m
S
H
IS
A
4
m
IC
A
M
5
kIC
A
M
5
kS
LC
38A
10
m
H
IS
T1H
3E
kH
IS
T1H
3E
m
C
A
R
M
1
kC
A
R
M
1
kR
U
N
X
1
kLM
N
A
m
N
P
E
P
L1
kN
P
E
P
L1
m
P
H
F19
kP
H
F19
siRNA Target
Clustering by siRNA TargetA
B
Figure 2. Heat maps of siRNA experiment data. Distance-based clustering (Euclidean) was used to determine global relationship
across all siRNA experiments, grouping data set according to either siRNA target (A) or by age gene response (B). Each column
represents mRNA expression data from single siRNA experiment, with every row being 1 of 20 measured genes. Letters “k” and
“m” preceding each gene symbol represents data from kidney and muscle cells, respectively. Seventy percent of siRNA-targeted
genes produced relatively consistent pattern of gene expression responses in both muscle and renal cells. Colors represent
magnitude of change in expression for each gene (red, down-regulated; blue, up-regulated) with siRNA treatment vs. controls.
6 Vol. 31 January 2017 CROSSLAND ET AL.The FASEB Journal x www.fasebj.org
 Vol.,  No. , pp:, November, 2016The FASEB Journal. 137.73.121.42 to IP www.fasebj.orgDownloaded from 
Fig. 2) and age classifier genes were examined. There
was a main effect of both TNF-a and staurosporine
treatment on gene expression (both P, 0.05 vs. vehicle
controls; Fig. 6C, D), but again these changes were sig-
nificantly different from the pattern of changes ob-
served in vivowith aging (P = 0.0004 for staurosporine,
P , 0.0001 for TNF-a with Fisher’s exact test). Thus,
only rapamycin demonstrated an in vitro response that
was consistent with what was observed in vivo.
DISCUSSION
Extensive studies in animal models and human tissues
have been undertaken to gain insights into the process of
aging and have identified many genes that show age-
dependent changes in expression (4, 27, 28). Nonetheless,
in most cases, each individual study identified a different
set of genes or did not apply rigorous classification
methods to verify consistency. Further, for all of the epi-
demiologically derivedmolecular signatures of aging, the
identified patterns of gene expression incorporate the ad-
ditional influences of clinical disease and/or drug treat-
ment (6, 29) and thus do not represent aging per se. The
present study was undertaken to examine the regulation
of our recently identified gene expression signature de-
rived from healthy older muscle tissue (5). This set of 150
genes was able to reproducibly classify young vs. older
humanmuscle, brain, and skin tissueacross 7 independent
cohorts. However, pathway analysis showed no enrich-
ment for any particular biologic process. Thus, analyses
into the regulation of these genes could help our un-
derstanding of healthy aging processes in humans if we
could regulate the signature inhumancellswithdrugsor if
one or more genes in the list regulated the other members
of the signature.
Our first set of experiments aimed to address whether
there were interactions between the age classifier genes
that couldbedriving the changes in expressionwithaging.
In doing so, we found that none of the individual age
genes, when down-regulated using siRNA, exactly mim-
icked alterations in mRNA seen in vivo, indicating it to be
unlikely that a single gene is driving our RNA signature.
Nonetheless, when the entire pattern of in vitro gene ex-
pression was examined, those genes up-regulated in vivo
clustered together as a distinct group in the in vitro data,
indicating a coordinated response to siRNA-mediated loss
of expression of genes seen to be down-regulated in
healthier older tissue in vivo. Whereas some genes ana-
lyzed had little impact on expression of other age genes
(PHF19, CARM1, NPEPL1), clear interactions between
other geneswere observed,motivating the need for future
investigation of the entire 150-gene set to identify the
Figure 3. Impact of ICAM5 and HIST1H3E knockdown on expression of age classiﬁer genes in human skeletal muscle and kidney
cells. Data are normalized to b-actin and expressed relative to controls (transfection reagent only). Bars represent means 6 SEM
from 2 to 3 independent experiments and for 2 different siRNAs targeting ICAM5 (A, B) or HIST1H3E (C, D) (n = 9–12 cell
culture well replicates). Red/blue bars represent down-/up-regulated genes with aging in vivo. *P , 0.05, **P , 0.01, ***P ,
0.001 vs. transfection reagent controls.
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nature of the gene networks comprising the healthy aging
signature.
One gene that influenced several of the age genes
was HIST1H3E. There is accumulating evidence that
widespread epigenetic changes occur throughout life,
including changes to histone posttranslational modifica-
tions andDNAmethylation patterns (30–32). For instance,
deletion of histone methylation complex components
extends life span in worms and flies (33, 34). The
HIST1H3E gene encodes the H3.1, a core component of
RUNX1 siRNA
AIMP2 siRNA
SLC38A10 siRNA NPEPL1 siRNA
CARM1 siRNA PHF19 siRNA
LMNA siRNA
SHISA4 siRNA
Figure 4. Impact of classiﬁer gene knockdown on expression of age classiﬁer genes in human skeletal muscle cells. Data are
normalized to b-actin and expressed relative to controls (transfection reagent only). Each bar represents mean 6 SEM from 2 to 3
independent experiments and for 2 different siRNAs targeting RUNX1 (A), SHISA4 (B), AIMP2 (C), LMNA (D), SLC38A10 (E),
NPEPL1 (F), CARM1 (G), or PHF19 (H) (n = 9–12 cell culture well replicates). Red/blue bars represent down-/up-regulated
genes with aging in vivo. *P , 0.05, **P , 0.01, ***P , 0.001 vs. transfection reagent controls.
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the nucleosome. Knockdown of HIST1H3E induced
similar changes in both kidney epithelial and skeletal
muscle cells, causing a reciprocal increase in the ex-
pression of ICAM5 and SHISA4, and down-regulation
of PHF19 and PCDH9. PHF19 is a polycomb-encoding
gene that functionally interacts with methylated his-
tone H3 (35). SHISA4, PCDH9, and ICAM5 all encode
cell surface proteins, but their potential links to
RUNX1 siRNA
AIMP2 siRNA
SLC38A10 siRNA NPEPL1 siRNA
CARM1 siRNA PHF19 siRNA
LMNA siRNA
SHISA4 siRNA
Figure 5. Impact of classiﬁer gene knockdown on expression of age classiﬁer genes in human kidney cells. Data are normalized to
b-actin and expressed relative to controls (transfection reagent only). Bars represent means 6 SEM from 2 to 3 independent
experiments and for 2 different siRNAs targeting RUNX1 (A), SHISA4 (B), AIMP2 (C), LMNA (D), SLC38A10 (E), NPEPL1 (F),
CARM1 (G), or PHF19 (H) (n = 9–12 cell culture well replicates). Red/blue bars represent down-/up-regulated genes with aging
in vivo. *P , 0.05, **P , 0.01, ***P , 0.001 vs. transfection reagent controls.
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epigenetic processes remain unclear. We analyzed
microarray expression patterns of additional histone
encoding genes within the same histone cluster as
HIST1H3E across age in a skeletal muscle data set
(Supplemental Fig. 4) to determine whether this age-
dependent change was unique to the HIST1H3E gene.
Although some genes within the cluster were down-
regulated with age, changes in HIST1H3E were the
most marked.
ICAM5 also regulated age gene expression, but it
appeared to affect different genes in kidney and skeletal
muscle cells. ICAM5 knockdown caused a reduction in
HIST1H3E expression inboth cell types, further supporting
a regulatory link between this adhesion molecule and his-
tone expression. In skeletalmuscle cells, ICAM5 influenced
expression of RUNX1, a transcription factor linked to his-
tone deacetylases; CARM1, a methyl-transferase that can
methylate histones; and SIRT5, a protein deacetylase. This
indicates that ICAM5 may have an important role regu-
lating gene expression and histonemodification processes.
Thus, furtherworkwill be required to explore the potential
role of ICAM5 in relation to aging and the possible link
between alterations in intercellular communication and
epigenetic regulation, 2 key features of the aging process.
Differing responses between human kidney and skeletal
muscle cells could have been due to differences in cell type
or due to other gene family members having dominant
roles in that cell type; or because the kidney cells were in a
proliferative state and muscle cells were differentiating.
Thus, even though thegeneswithin thisRNAsignature are
able to accurately classify age of multiple human tissues in
vivo, the relative functional importanceof thesegenes could
vary in different cell types.
Although RUNX1 had little impact on overall expres-
sion of the age classifier genes, knockdown did cause a
significant increase in CD36 expression in muscle cells.
CD36 is a transmembrane glycoprotein that has pre-
viously been reported to increase with aging and may be
important for clearance of circulating oxidized lipids (36).
CD36mayalso contribute to accumulation of lipidswithin
cardiacmyocytes andhencecardiomyopathy inagedmice
(37). CD36 has been shown to contain RUNX-binding el-
ements, and RUNX3 can repress CD36 expression in my-
eloid cells (38). Little is understood about the potential link
of RUNX1 to age-related pathways, although it is a ge-
nomicmediator of adaptation to exercise (39, 40) and thus
may be an example of a key determinant of age–gene–
environmental interactions. Whether increased CD36 ex-
pression with aging is protective or damaging is unclear,
but this changemay be the result of reduced expression of
RUNX transcription factors.
Lamins form amajor component of the nuclear lamina,
which is crucial for genomic stability because it provides a
scaffold for chromatin and protein complexes (41). Muta-
tion of the lamin genes cause accelerated aging syndromes
such as Hutchinson-Gilford progeria syndrome. Thus, it
represented an ideal target to study in relation to our age
genes. It has been reported that normal aging is associated
with accumulation of progerin (the aberrant prelamin A
isoform),whichmaybe linked to histonemodification and
DNA damage (42), a feature that accompanies aging.
LMNAknockdown in kidney cells had little impact on age
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Figure 6. Impact of resveratrol (A), rapamycin (B), TNF-a (C), and staurosporine (D) treatment on expression of age classiﬁer
genes in skeletal muscle cells. Cells were treated for 24 h with 100 nM rapamycin, 50 mM resveratrol, 10 ng/ml TNF-a, or 10 nM
staurosporine (n = 3), and experiments were performed over 3 passages. Data are normalized to b-actin and expressed relative to
DMSO or BSA controls. Blue/red bars represent down-/up-regulated genes with aging in vivo.
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gene expression, but in muscle, there appeared to be a
general increase in mRNA abundance. This was also ob-
served for AIMP2, a gene required for assembly of the
aminoacyl-tRNA synthase complex (43), and SLC38A10, a
neutral amino acid transporter. These observations sug-
gest that reduced expression of these genes may have
influenced generalmRNA translation, resulting in general
accumulation of mRNA transcripts. It would seem critical
that a future analysis examines the posttranscriptional
regulation of these markers of healthy older tissue using,
for example analysis of the mRNA engaged with the
translational machinery.
Our secondmajor aimwas to determine links between
positive/negative aging compounds and our age genes.
Each of the 4 age-related compounds screened caused
significant changes in gene expression for positive control
genes as assessed by ANOVA (Supplemental Fig. 2) and
when compared to vehicle control, but only rapamycin
yielded gene expression changes in a pattern that was
consistent with what we observed in vivowith age (Fig. 1)
(5). Indeed, Fisher’s exact test revealed that the RNA
profile of rapamycin was not significantly distinguishable
from in vivo muscle aging (i.e., genes that were up-
regulated in vivo were more frequently up-regulated by
rapamycin, and vice versa). Although the directional
changes and consistency with the in vivo pattern were
established using unbiased statistical analysis, the di-
rectional overlap was not 100%. However, because we
were comparing gene expression changes in a primary cell
model system measured over periods of days to in vivo
changes with aging over decades, one might not expect
complete concordance. The protein kinase mTOR re-
sponds to a variety of signals including growth factors,
energy status, stress, and amino acids to regulate cell
growth and metabolism (19). mTOR forms part of 2 dis-
tinct complexes, mTORC1 and mTORC2; mTORC1 is a
critical regulator of protein synthesis and autophagy,
whereas mTORC2 may have a predominant role in glu-
cose metabolism and cell survival. Rapamycin has been
shown to specifically target mTORC1, but chronic treat-
ment can also inhibit mTORC2 (44). With a growing
number of studies reporting beneficial effects of rapamy-
cin on extension of life span and health span (18, 20, 22),
this indicates that these gene expression markers for
healthy tissueagewarrant furtherdetailed investigation in
relation to their potential regulationbyor linkwithmTOR.
Theeffect of resveratrol onexpressionof thehealthyage
genes was assessed. Previous studies on resveratrol dem-
onstrated its ability to extend life span in C. elegans,
Drosophila melanogaster, and S. cerevisiae (14, 16). It was
reported that the beneficial effects of resveratrol may be
mediated through activation of sirtuins, though resvera-
trol can also activate AMPK signaling (14, 15). In rodents,
reduced risk of death due to high-calorie feeding was ob-
served inmicewith resveratrol treatment (17). In humans,
resveratrol has some reported benefits on metabolic pa-
rameters (insulin sensitivity, fatmetabolism),mimicking a
caloric restriction phenotype (45). In this study, changes in
expression of the age genes did not significantly replicate
the directional changes with healthy aging in vivo, despite
seeing an effect of rapamycin, which is also viewed as a
calorie-restrictionmimetic. This implies that the age genes
were not directly regulated by SIRT1- orAMPK-activated
pathways.
We also examined whether our healthy aging RNA
signature might be linked to any inflammatory or oxida-
tive stress–related pathways. Inflammation-induced tis-
sue damage has been proposed to accumulatewith aging,
potentially as a result of reduced autophagic capacity or
buildupof senescent cells (23, 24).AccumulationofROS is
thought to lead to widespread cellular damage with ag-
ing, although conflicting evidence regarding the role of
ROS in aging has been reported (26, 46, 47). Expression of
many of the age classifier genes responded to treatment
with TNF-a and staurosporine; however, the changes
were inconsistentwith the in vivodirectional age changes,
and it was clear that both treatments caused cell stress
responses that would have mostly likely influenced
thousands of other genes. This suggests that in vivo, these
age genes are not being influenced by inflammatory or
oxidative stress–related pathways.
In summary, we have demonstrated in vitro co-
ordination of gene expression within our in vivo validated
tissue age signature, as well as potential epigenetic inter-
actions. Further analysis of the interactions between the
entire 150genes andtheir potential link tomTORsignaling
is merited.
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